SonoScape Medical Corp (300633) - Total Assets
Based on the latest financial reports, SonoScape Medical Corp (300633) holds total assets worth CN¥4.12 Billion CNY (≈ $602.30 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See SonoScape Medical Corp shareholders equity for net asset value and shareholders' equity analysis.
SonoScape Medical Corp - Total Assets Trend (2012–2024)
This chart illustrates how SonoScape Medical Corp's total assets have evolved over time, based on quarterly financial data.
SonoScape Medical Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
SonoScape Medical Corp's total assets of CN¥4.12 Billion consist of 69.0% current assets and 31.0% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 36.4% |
| Accounts Receivable | CN¥237.54 Million | 5.5% |
| Inventory | CN¥653.08 Million | 15.1% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥155.65 Million | 3.6% |
| Goodwill | CN¥112.51 Million | 2.6% |
Asset Composition Trend (2012–2024)
This chart illustrates how SonoScape Medical Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of SonoScape Medical Corp.
Key Asset Composition Facts
- Current vs. Non-Current Assets: SonoScape Medical Corp's current assets represent 69.0% of total assets in 2024, an increase from 67.0% in 2012.
- Cash Position: Cash and equivalents constituted 36.4% of total assets in 2024, up from 14.1% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, a decrease from 26.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 15.1% of total assets.
SonoScape Medical Corp Competitors by Total Assets
Key competitors of SonoScape Medical Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cochlear Ltd
AU:COH
|
Australia | AU$2.83 Billion |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
MicroPort Endovascular MedTech Ltd
SHG:688016
|
China | CN¥4.64 Billion |
|
Shandong Weigao Orthopaedic Device Co. Ltd. A
SHG:688161
|
China | CN¥5.04 Billion |
|
Sino Medical Sciences Technology In
SHG:688108
|
China | CN¥1.34 Billion |
|
4DMEDICAL Ltd
AU:4DX
|
Australia | AU$139.55 Million |
|
Beijing Succeeder Technology Inc
SHG:688338
|
China | CN¥1.75 Billion |
SonoScape Medical Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.04 | 3.09 | 1.80 |
| Quick Ratio | 2.01 | 2.26 | 1.43 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥1.79 Billion | CN¥1.95 Billion | CN¥663.33 Million |
SonoScape Medical Corp - Advanced Valuation Insights
This section examines the relationship between SonoScape Medical Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.48 |
| Latest Market Cap to Assets Ratio | 0.35 |
| Asset Growth Rate (YoY) | 14.4% |
| Total Assets | CN¥4.31 Billion |
| Market Capitalization | $1.52 Billion USD |
Valuation Analysis
Below Book Valuation: The market values SonoScape Medical Corp's assets below their book value (0.35x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: SonoScape Medical Corp's assets grew by 14.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for SonoScape Medical Corp (2012–2024)
The table below shows the annual total assets of SonoScape Medical Corp from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥4.31 Billion ≈ $631.13 Million |
+14.36% |
| 2023-12-31 | CN¥3.77 Billion ≈ $551.88 Million |
+6.41% |
| 2022-12-31 | CN¥3.54 Billion ≈ $518.63 Million |
+17.34% |
| 2021-12-31 | CN¥3.02 Billion ≈ $441.97 Million |
+34.12% |
| 2020-12-31 | CN¥2.25 Billion ≈ $329.53 Million |
-6.73% |
| 2019-12-31 | CN¥2.41 Billion ≈ $353.30 Million |
+31.53% |
| 2018-12-31 | CN¥1.84 Billion ≈ $268.61 Million |
+37.47% |
| 2017-12-31 | CN¥1.34 Billion ≈ $195.40 Million |
+31.36% |
| 2016-12-31 | CN¥1.02 Billion ≈ $148.75 Million |
+8.64% |
| 2015-12-31 | CN¥935.73 Million ≈ $136.93 Million |
+9.02% |
| 2014-12-31 | CN¥858.30 Million ≈ $125.60 Million |
+37.16% |
| 2013-12-31 | CN¥625.75 Million ≈ $91.57 Million |
+0.70% |
| 2012-12-31 | CN¥621.41 Million ≈ $90.93 Million |
-- |
About SonoScape Medical Corp
SonoScape Medical Corp., together with its subsidiaries, engages in the research, development, production, and sale of medical diagnosis and treatment equipment in China and internationally. The company offers ultrasound medical imaging products comprising trolley and portable color dopplers, B/W ultrasounds, and transducers; endoscopic diagnosis and treatment products consisting of image process… Read more